The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus Type 1

New England Journal of Medicine

Volumn 322, Issue 3, 1990, Pages 166-172

  Fahey, John L ^a   Taylor, Jeremy M g ^b   Detels, Roger ^b   Hofmann, bo ^a   Melmed, Raphael ^a   Nishanian, Pari ^a   Giorgi, Janis V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; IMMUNOGLOBULIN A; INTERLEUKIN 2 RECEPTOR; NEOPTERIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; HELPER CELL; HUMAN; PRIORITY JOURNAL; SUPPRESSOR CELL;

EID: 0025069873     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199001183220305     Document Type: Article

References (38)

1. Fahey JL, Prince H, Weaver M, et al. Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders. Am J Med 1984; 76: 95–100.
2. Fauci AS, Macher AM, Longo DL, et al. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic consideration. Ann Intern Med 1984; 100: 92–106.
3. Melbye M, Biggar RJ, Ebbesen P, et al. Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities: a longitudinal study. Ann Intern Med 1986; 104: 496–500.
4. Goedert JJ, Biggar RJ, Weiss SH, et al. Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science 1986; 231: 992–5.
5. Polk BF, Fox R, Brookmeyer R, et al. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med 1987; 316: 61–6.
6. Detels R, Visscher BR, Fahey JL, et al. Predictors of clinical AIDS in young homosexual men in a high-risk area. Int J Epidemiol 1987; 16: 271–6.
7. Detels R, English PA, Giorgi JV, et al. Patterns of CD4+ cell changes after HIV-1 infection indicate the existence of a codeterminant of AIDS. J Acquir Immune Defic Syndr 1988; 1: 390–5.
8. Munoz A, Carey V, Saah AJ, et al. Predictors of decline in CD4 lymphocytes in a cohort of homosexual men infected with human immunodeficiency virus. J Acquir Immune Defic Syndr 1988; 1: 396–404.
9. Lane HC, Depper JM, Greene WC, Whalen G, Waldmann TA, Fauci AS. Quantitative analysis of immune function in patients with the acquired immunodeficiency syndrome: evidence for a selective defect in soluble antigen recognition. N Engl J Med 1985; 313: 79–84.
10. Prince HE, Kermani-Arab V, Fahey JL. Depressed interleukin 2 receptor expression in acquired immune deficiency and lymphadenopathy syndromes. J Immunol 1984; 133: 1313–7.
11. Hofmann B, Lindhardt BO, Gerstoft J, et al. Lymphocyte transformation response to pokeweed mitogen as a predictive marker for development of AIDS and AIDS related symptoms in homosexual men with HIV antibodies. Br Med J 1987; 295: 293–6.
12. Giorgi JV, Fahey JL, Smith DC, et al. Early effects of HIV on CD4 lymphocytes in vivo. J Immunol 1987; 138: 3725–30.
13. Salazar-Gonzalez JF, Moody DJ, Giorgi JV, Martinez-Maza O, Mitsuyasu RT, Fahey JL. Reduced ecto-5′-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity. J Immunol 1985; 135: 1778–85.
14. Giorgi JV, Nishanian PG, Schmid I, Hultin LE, Cheng HL, Detels R. Selective alterations in immunoregulatory lymphocyte subsets in early HIV (human T-lymphotropic virus type III/lymphadenopathy-associated virus) infection. J Clin Immunol 1987; 7: 140–50.
15. Giorgi JV, Detels R. T cell alterations in HIV infected homosexual men. Clin Immunol Immunopathol (in press).
16. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983; 309: 453–8.
17. Martinez-Maza O, Crabb E, Mitsuyasu RT, Fahey JL, Giorgi JV. Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. J Immunol 1987; 138: 3720–4.
18. Huber C, Batchelor JR, Fuchs D, et al. Immune response-associated production of neopterin: release from macrophages primarily under control of interferon-gamma. J Exp Med 1984; 160: 310–6.
19. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunol Today 1988; 9: 150–5.
20. Ziegler I, Rokos H. Pteridines and the immune response. J Immunol Immunopharm 1986; 6: 169–77.
21. Melmed RN, Taylor JM, Detels R, Bozorgmehri M, Fahey JL. Serum neopterin changes in HIV-infected subjects: indicator of significant pathology, CD4 T cell change, and the development of AIDS. J Acquir Immune Defic Syndr 1989; 2: 70–6.
22. Moss AR, Bacchetti P, Osmond D, et al. Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br Med J 1988; 296: 745–50.
23. Lacey JN, Forbes MA, Waugh MA, Cooper EH, Hambling MH. Serum beta2-microglobulin and human immunodeficiency virus infection. AIDS 1987; 1: 123–7.
24. Hofmann B, Wang Y, Cumberland WG, Detels R, Bozorgmehri M, Fahey JL. Immune activation by HIV: seroconversion and progression in serum beta2-microglobulin. AIDS (in press).
25. Prince HE, Kleinman S, Williams AE. Soluble IL-2 receptor levels in blood donors seropositive for HIV. J Immunol 1988; 140: 1139–41.
26. de Wolf F, Goudsmit J, Paul DA, et al. Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia. Br Med J 1987; 295: 569–72.
27. Allain JP, Laurian Y, Paul DA, et al. Long-term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia: potential clinical importance. N Engl J Med 1987; 317: 1114–21.
28. Taylor JM, Fahey JL, Detels R, Giorgi JV. CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. J Acquir Immune Defic Syndr 1989; 2: 114–24.
29. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR Jr. The Multicenter AIDS Cohort study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987; 126: 310–8.
30. Chmiel JS, Detels R, Kaslow RA, Van Raden M, Kingsley LA, Brookmeyer R. Factors associated with prevalent human immunodeficiency virus (HIV) infection in Multicenter AIDS Cohort study. Am J Epidemiol 1987; 126: 568–77.
31. Nishanian P, Taylor JM, Korns E, Detels R, Saah A, Fahey JL. Significance of quantitative enzyme-linked immunosorbent assay (ELISA) results in evaluation of three ELIS As and Western blot tests for detection of antibodies to human immunodeficiency virus in a high-risk population. J Clin Microbiol 1987; 25: 395–400.
32. Fahey JL, Giorgi J, Martinez-Maza O, Detels R, Mitsuyasu R, Taylor J. Immune pathogenesis of AIDS and related syndromes. Ann Inst Pasteur Immunol 1987; 138: 245–52.
33. Wittek AE, Phelan MA, Wells MA, et al. Detection of human immunodeficiency virus core protein in plasma by enzyme immunoassay: association of antigenemia with symptomatic disease and T-helper cell depletion. Ann Intern Med 1987; 107: 286–92.
34. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81.
35. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972; 34: 187–220.
36. Nakajima K, Martinez-Maza O, Hirano T, et al. Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV. J Immunol 1989; 142: 531–6.
37. McDougal JS, Mawle A, Cort SP, et al. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen. J Immunol 1985; 135: 3151–62.
38. Lelie PN, Reesink HW, Bakker E, Huisman JG, ten Veen JH. Clinical importance of HIV antigen and anti-HIV core markers in persons infected with HIV. N Engl J Med 1988; 318: 1204–5.